2’,3’‐Protected Nucleotides as Building Blocks for Enzymatic de novo RNA Synthesis
Chemistry – A European Journal · 25.04.2024 · 30 (24)
DOI: 10.1002/chem.202400137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, online erschienen am 13.03.2024. Verfasst von Maëva Pichon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institut Pasteur, Université Paris Cité, CNRS UMR3523, Department of Structural Biology and Chemistry, Laboratory for Bioorganic Chemistry of Nucleic…. Hauptthemen laut MEDLINE: RNA, DNA-Directed RNA Polymerases. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 123 Literaturangaben. Gefördert von: Institut Pasteur, Sanofi.
Abstract (Originalsprache)
Besides being a key player in numerous fundamental biological processes, RNA also represents a versatile platform for the creation of therapeutic agents and efficient vaccines. The production of RNA oligonucleotides, especially those decorated with chemical modifications, cannot meet the exponential demand. Due to the inherent limits of solid‐phase synthesis and in vitro transcription, alternative, biocatalytic approaches are in dire need to facilitate the production of RNA oligonucleotides. Here, we present a first step towards the controlled enzymatic synthesis of RNA oligonucleotides. We have explored the possibility of a simple protection step of the vicinal cis‐diol moiety to temporarily block ribonucleotides. We demonstrate that pyrimidine nucleotides protected with acetals, particularly 2′,3′‐ O ‐isopropylidene, are well‐tolerated by the template‐independent RNA polymerase PUP (polyU polymerase) and highly efficient coupling reactions can be achieved within minutes – an important feature for the development of enzymatic de novo synthesis protocols. Even though purines are not equally well‐tolerated, these findings clearly demonstrate the possibility of using cis ‐diol‐protected ribonucleotides combined with template‐independent polymerases for the stepwise construction of RNA oligonucleotides.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut Pasteur, Université Paris Cité, CNRS UMR3523, Department of Structural Biology and Chemistry, Laboratory for Bioorganic Chemistry of Nucleic Acids, 28, rue du Docteur Roux, 75724, Paris Cedex 15, France.
ORCID-Profile: Maëva Pichon, Marcel Hollenstein
Förderung
- Institut Pasteur
- Sanofi
Zitieren
APA
Pichon, M., Levi-Acobas, F., Kitoun, C., & Hollenstein, M. (2024). 2’,3’‐Protected Nucleotides as Building Blocks for Enzymatic de novo RNA Synthesis. Chemistry – A European Journal, 30(24). https://doi.org/10.1002/chem.202400137
Vancouver
Pichon M, Levi-Acobas F, Kitoun C, Hollenstein M. 2’,3’‐Protected Nucleotides as Building Blocks for Enzymatic de novo RNA Synthesis. Chemistry – A European Journal. 2024;30(24). doi:10.1002/chem.202400137
BibTeX
@article{Pichon2024,
author = {Pichon, Maëva and Levi-Acobas, Fabienne and Kitoun, Camélia and Hollenstein, Marcel},
title = {2’,3’‐Protected Nucleotides as Building Blocks for Enzymatic de novo RNA Synthesis},
journal = {Chemistry – A European Journal},
year = {2024},
volume = {30},
number = {24},
doi = {10.1002/chem.202400137}
}
EUVIMED